-
1
-
-
50449132190
-
Diabetic angiopathy, a specific vascular disease
-
Lundbæk K. Diabetic angiopathy, a specific vascular disease. Lancet 1954; 1: 377-9.
-
(1954)
Lancet
, vol.1
, pp. 377-379
-
-
Lundbæk, K.1
-
2
-
-
0000072168
-
Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas
-
Mogensen CE (ed.) Boston, Dordrecht, London. Kluwer Academic Publishers
-
Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas. In Mogensen CE (ed.) The Kidney and Hypertension in Diabetes Mellitus, 5th ed. Boston, Dordrecht, London. Kluwer Academic Publishers, 2000:655-706.
-
(2000)
The Kidney and Hypertension in Diabetes Mellitus, 5th Ed.
, pp. 655-706
-
-
Mogensen, C.E.1
-
3
-
-
0032511558
-
Combined high blood pressure and glucose in type 2 diabetes: Double Jeopardy
-
Mogensen CE. Combined high blood pressure and glucose in type 2 diabetes: Double Jeopardy. BMJ 1998; 317: 693-4.
-
(1998)
BMJ
, vol.317
, pp. 693-694
-
-
Mogensen, C.E.1
-
4
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients
-
The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients. New Engl J Med 2000; 342: 145-53.
-
(2000)
New Engl J Med
, vol.342
, pp. 145-153
-
-
-
5
-
-
0034700790
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
-
Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9.
-
(2000)
Lancet
, vol.355
, pp. 253-259
-
-
-
6
-
-
0034628425
-
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
-
The Diabetes Control and Complications Trial Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381-9.
-
(2000)
N Engl J Med
, vol.342
, pp. 381-389
-
-
-
7
-
-
0032511580
-
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38
-
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38. BMJ 1998; 317:703-13.
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
-
8
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 13:1755-62.
-
(1998)
Lancet
, vol.13
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
-
9
-
-
0033055724
-
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
-
Gæde P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 1999; 353: 617-22.
-
(1999)
Lancet
, vol.353
, pp. 617-622
-
-
Gæde, P.1
Vedel, P.2
Parving, H.-H.3
Pedersen, O.4
-
10
-
-
0033069767
-
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension
-
Guidelines subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17:151-83.
-
(1999)
J Hypertens
, vol.17
, pp. 151-183
-
-
-
11
-
-
0033034404
-
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The captopril Prevention Project (CAPPP) randomised trial
-
Hansson L, Lindholm LH, Niskanen L et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353:611-16.
-
(1999)
Lancet
, vol.353
, pp. 611-616
-
-
Hansson, L.1
Lindholm, L.H.2
Niskanen, L.3
-
12
-
-
0032485350
-
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
-
Estacio RO, Jeffers BW, Hiatt WR et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338:645-53.
-
(1998)
N Engl J Med
, vol.338
, pp. 645-653
-
-
Estacio, R.O.1
Jeffers, B.W.2
Hiatt, W.R.3
-
13
-
-
0033522149
-
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
-
Toumilehto J, Rastenyte D, Birkenhäger W et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340; 677-84.
-
(1999)
N Engl J Med
, vol.340
, pp. 677-684
-
-
Toumilehto, J.1
Rastenyte, D.2
Birkenhäger, W.3
-
14
-
-
0033589756
-
Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
-
Hansson L, Lindholm LH, Ekbom T et al. for the STOP-Hypertension-2 study Group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354:1751-6.
-
(1999)
Lancet
, vol.354
, pp. 1751-1756
-
-
Hansson, L.1
Lindholm, L.H.2
Ekbom, T.3
-
15
-
-
85088333898
-
Randomised controlled trial of dual blockade of the renin-angiotensin system in hypertensive, microalbuminuric, non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
-
(Submitted for publication)
-
Mogensen CE, Neldam S, Tikkannen I et al. for the CALM Study Group. Randomised controlled trial of dual blockade of the renin-angiotensin system in hypertensive, microalbuminuric, non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000. (Submitted for publication)
-
(2000)
BMJ
-
-
Mogensen, C.E.1
Neldam, S.2
Tikkannen, I.3
-
16
-
-
0021236983
-
Predicting diabetic nephropathy in insulin-dependent patients
-
Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311:89-93.
-
(1984)
N Engl J Med
, vol.311
, pp. 89-93
-
-
Mogensen, C.E.1
Christensen, C.K.2
-
17
-
-
0026731377
-
Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes
-
Mogensen CE, Østerby R, Hansen KW, Damsgaard EM. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992; 15: 1192-204.
-
(1992)
Diabetes Care
, vol.15
, pp. 1192-1204
-
-
Mogensen, C.E.1
Østerby, R.2
Hansen, K.W.3
Damsgaard, E.M.4
-
18
-
-
0028867689
-
Prevention of diabetic renal disease with special reference to microalbuminuria
-
Mogensen CE, Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080-4.
-
(1995)
Lancet
, vol.346
, pp. 1080-1084
-
-
Mogensen, C.E.1
Keane, W.F.2
Bennett, P.H.3
-
19
-
-
0029279966
-
Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion
-
Mogensen CE, Vestbo E, Poulsen PL et al. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 1995; 18: 572-81.
-
(1995)
Diabetes Care
, vol.18
, pp. 572-581
-
-
Mogensen, C.E.1
Vestbo, E.2
Poulsen, P.L.3
-
20
-
-
0028011891
-
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
-
Viberti GC, Mogensen CE, Groop L, Pauls JF for the European Microalbuminuria Captopril Study Group. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275-9.
-
(1994)
JAMA
, vol.271
, pp. 275-279
-
-
Viberti, G.C.1
Mogensen, C.E.2
Groop, L.3
Pauls, J.F.4
-
21
-
-
0028860451
-
The beneficial effect of angiotensin-converting-enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
-
Laffel LMB, McGill JB, Gans DJ on behalf of the North American Microalbuminuria Study Group. The beneficial effect of angiotensin-converting-enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995; 99: 497-504.
-
(1995)
Am J Med
, vol.99
, pp. 497-504
-
-
Laffel, L.M.B.1
McGill, J.B.2
Gans, D.J.3
-
22
-
-
0030908772
-
Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
-
The Euclid Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-92.
-
(1997)
Lancet
, vol.349
, pp. 1787-1792
-
-
-
23
-
-
0001160284
-
ACE inhibition during two years did not improve urinary excretion in normotensive microalbuminuric patients
-
Bojestig M, Karlberg B, Verho M and the Prima Study Group. ACE inhibition during two years did not improve urinary excretion in normotensive microalbuminuric patients. Diabetologia 1998; 41: A544.
-
(1998)
Diabetologia
, vol.41
-
-
Bojestig, M.1
Karlberg, B.2
Verho, M.3
-
25
-
-
0033519752
-
Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria
-
Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving H-H. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 1999; 319; 24-5.
-
(1999)
BMJ
, vol.319
, pp. 24-25
-
-
Mathiesen, E.R.1
Hommel, E.2
Hansen, H.P.3
Smidt, U.M.4
Parving, H.-H.5
-
26
-
-
0346879995
-
ACE inhibition vs. calcium-channel blockade in normotensive type 1 and type 2 diabetic patients with microalbuminuria
-
Jerums G on behalf of the Melbourne Diabetic Nephropathy Study Group, Melbourne, Australia. ACE inhibition vs. calcium-channel blockade in normotensive type 1 and type 2 diabetic patients with microalbuminuria. Nephrology Dial Trans 1998; 13: 1065-66.
-
(1998)
Nephrology Dial Trans
, vol.13
, pp. 1065-1066
-
-
Jerums, G.1
-
27
-
-
0347510523
-
Early ACE-I intervention in microalbuminuria: 24h BP, renal function and exercise changes. Abstract of the 34th Annual Meeting of the EASD Barcelona, Spain 8-12 Sept. 1998
-
Ebbehoj E, Poulsen PL, Nosadini R, Fioretto R, Fioretto P, Crepaldi C, Mogensen CE. Early ACE-I intervention in microalbuminuria: 24h BP, renal function and exercise changes. Abstract of the 34th Annual Meeting of the EASD Barcelona, Spain 8-12 Sept. 1998. Diabetologia 1998; 41(1).
-
(1998)
Diabetologia
, vol.41
, Issue.1
-
-
Ebbehoj, E.1
Poulsen, P.L.2
Nosadini, R.3
Fioretto, R.4
Fioretto, P.5
Crepaldi, C.6
Mogensen, C.E.7
-
28
-
-
0032967512
-
Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type 1 (insulin-dependent) diabetes mellitus
-
Rudberg S, Østerby R, Bangstad H-J, Dahlquiest G, Persson B. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 589-95.
-
(1999)
Diabetologia
, vol.42
, pp. 589-595
-
-
Rudberg, S.1
Østerby, R.2
Bangstad, H.-J.3
Dahlquiest, G.4
Persson, B.5
-
30
-
-
0343522604
-
The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
-
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 118: 577-81.
-
(1993)
N Engl J Med
, vol.118
, pp. 577-581
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Bain, R.P.3
Rohde, R.D.4
-
32
-
-
0019965181
-
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
-
Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982; 285:685-8.
-
(1982)
BMJ
, vol.285
, pp. 685-688
-
-
Mogensen, C.E.1
-
33
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Stratton IM, Adler AI, Neil AW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
-
(2000)
BMJ
, vol.321
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, A.W.3
-
34
-
-
0034641550
-
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
-
Adler AI, Stratton IM, Neil AW et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9.
-
(2000)
BMJ
, vol.321
, pp. 412-419
-
-
Adler, A.I.1
Stratton, I.M.2
Neil, A.W.3
|